NEUROSONOLOGY

Intima-media thickness (IMT)

Created 26/03/2021, last revision 09/01/2023

  • carotid intima-media thickness (IMT, CIMT) measurement can quantify atherosclerosis burden in asymptomatic patients, which may need a more aggressive approach to managing vascular risk factors
  • the standard measurement is performed in B-mode on the far wall of the CCA, 10 mm proximal to the bifurcation
    • use high-resolution images
    • optimize the insonation angle (90° to the vessel wall)
  • measure the distance between the 2 echogenic lines
    • the 1st line is the lumen-intima interface
    • the 2nd line is the media-adventitia interface
  • obtain at least five measurements on each side and get an average value (“average IMT”); specialized software may be helpful  Automated IMT measurement (GE LOGIQ) [Baldassare, 2000]
  • avoid atherosclerotic plaques when measuring IMT (lesions > 1.5 mm are already considered plaque)
  • echogenicity, especially of the media, may be increased in the presence of fatty infiltration and thickening
  • IMT > 95th. percentile for age and sex is considered abnormal (usually IMT >1 mm is abnormal)
Carotid intima-media thickness (CIMT)
Intima-media thickness (IMT) on ultrasound imaging
Female (95. percentile)
Male (95. percentile)
45 y
55 y
65 y
45 y 55 y
65 y
0.73
0.91 1.04
0.89
1 1.3

95.th percentile  [Howard, 1993]

Age
P25 P50
P75
Men <30 0.39 0.43 0.48
Men 31-40  0.42 0.46 0.50
Men 41-50 0.46 0.50 0.57
Men >50  0.46 0.52 0.62
Women <30 0.39 0.40 0.43
Women 31-40 0.42 0.45 0.49
Women 41-50 0.44 0.48 0.53
Women >50 0.50 0.54 0.59

Prognostic value of IMT measurement

  • not only atherosclerotic plaques but also IMT can quantify atherosclerosis burden in asymptomatic patients
  • IMT should be assessed in each extracranial ultrasound examination
    • increased IMT is the first stage of atherosclerosis and, if left untreated, is followed by plaque formation
    • clinical and epidemiological studies have shown an association between IMT and coronary artery disease (CAD), stroke, and peripheral vascular disease (PAD) (ROTTERDAM, ACAPS trials ) [Lorenz, 2007]
    • thickening of IMT correlates with the presence of traditional vascular risk factors (BMI, hypertension, hypercholesterolemia, diabetes, smoking)
    • some authors recommend including IMT and the presence of AS plaques among the classic vascular risk factors [Chambless, 2010]
    • some publications question the importance of IMT in predicting CV events [Costanzo, 2010] [Ruijter, 2012]
  • detection of subclinical atherosclerosis is important in patients with borderline risk and multiple risk factors, as it moves the patient into the high-risk category (SCORE ≥ 5%) with all therapeutic consequences
  • pharmacological studies have shown a reduction in the rate of progression of IMT with hypolipidemic therapy and antihypertensive drugs (ACAPS, METEOR)
    • rosuvastatin did not induce disease regression
  • on the other hand, a meta-analysis of 41 randomized trials showed regression of cardiovascular events with hypolipidemic drugs but did not show a relationship between a decrease in CV events and a regression of IMT [Costanzo, 2010]
  • an increase in IMT can also be found in non-atherosclerotic diseases (e.g., Takayasu´s arteritis)
Send this to a friend
Hi,
you may find this topic useful:

Intima-media thickness (IMT)
link: https://www.stroke-manual.com/intima-media-thickness-imt/